SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-172735
Filing Date
2018-05-24
Accepted
2018-05-24 07:10:35
Documents
4
Period of Report
2018-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d590805d8k.htm 8-K 23169
2 EX-99.1 d590805dex991.htm EX-99.1 26533
3 GRAPHIC g590805g57o95.jpg GRAPHIC 8711
4 GRAPHIC g590805g89b65.jpg GRAPHIC 9893
  Complete submission text file 0001193125-18-172735.txt   76752
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 18856628
SIC: 2834 Pharmaceutical Preparations